SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-16-018136
Filing Date
2016-05-06
Accepted
2016-05-06 07:02:40
Documents
3
Period of Report
2016-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ctmx-8k_20160506.htm 8-K 33522
2 EX-99.1 ctmx-ex991_6.htm EX-99.1 16094
3 GRAPHIC gkgrnorwc022000001.jpg GRAPHIC 4559
  Complete submission text file 0001564590-16-018136.txt   57219
Mailing Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37587 | Film No.: 161625864
SIC: 2834 Pharmaceutical Preparations